Abivax ABVX
NASDAQ ABVX
$96.85 +5.79 (+6.36%)
At close: Sep 28, 2026 · 4:00 PM EDT

Abivax (ABVX) Change in Accured Expenses (2024 - 2025)

Updated

Abivax (ABVX) reported Change in Accured Expenses of $72.48 billion for Q4 2025, compared with $1.51 billion a year earlier.

Analysis

Abivax (ABVX) Change in Accured Expenses (2024 - 2025) Analysis & Trends

For FY2025, Abivax posted Change in Accured Expenses of $70.42 billion.

  • By year, Change in Accured Expenses came in at $1.53 billion in FY2024 and -$1.25 billion in FY2023.
  • Per Business Quant data, the three quarters before Q4 2025 came in at $73.95 million (Q3 2025), -$2.28 million (Q2 2025) and $1.14 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 2.96 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 1.20 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -251.00 Mn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 901.00 Mn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 338.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 222.50 Mn
10 Abivax 7.15 Bn 7.15 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 72.48 Bn
Sep 30, 2025 73.95 Mn
Jun 30, 2025 -2.28 Mn
Mar 31, 2025 1.14 Mn
Dec 31, 2024 1.51 Bn
API Access

Abivax Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ABVX&period=max&api_key=YOUR_API_KEY